Chattanooga Hem/Oncology Ass (SCRI) — Chattanooga, Tennessee

Chattanooga Hem/Oncology Ass (SCRI) is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Chattanooga Hem/Oncology Ass (SCRI) has participated in 1 clinical trials.

Therapeutic areas: Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chattanooga Hem/Oncology Ass (SCRI)?

Chattanooga Hem/Oncology Ass (SCRI) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chattanooga Hem/Oncology Ass (SCRI) conducted?

Chattanooga Hem/Oncology Ass (SCRI) has 1 clinical trials on record. Their work covers Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma.

Is Chattanooga Hem/Oncology Ass (SCRI) accredited by Crixeo Health?

Chattanooga Hem/Oncology Ass (SCRI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chattanooga Hem/Oncology Ass (SCRI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.